ATLANTA, Feb. 24, 2020 /PRNewswire/ -- The National Association of Chronic Disease Directors (NACDD) has published its annual

OAKLAND, Calif., Feb. 24, 2020 /PRNewswire/ -- Blue Shield of California has appointed Lisa Davis as the nonprofit health plan's chief information officer. Davis will be responsible for leading the company's ongoing efforts to modernize with new technologies to better serve its more than 4 million membe

BOISE, Idaho, Feb. 24, 2020 /PRNewswire/ -- As the preferred credit union of the Boise State Broncos, Mountain America Credit Union

FREMONT, Calif., Feb. 24, 2020 /PRNewswire/ -- Today, SimpleTherapy officially announced the debut of its Musculoskeletal Injury Prevention Program (MIPP). This brand new, first-of-its-kind service  focuses on providing value to both the employees and employers. Employees can decrease the risk of suffering sprains and strains by maintaining healthy muscles and joint

MIAMI, Feb. 24, 2020 /PRNewswire/ -- A new study marks a significant advance in developing a gene therapy for X-linked retinitis pigmentosa, a hereditary disease that leads to severe sight loss in young males.

DUBLIN, Feb. 24, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the fourth quarter and full year ended December 31, 2019. Revenue for the fourth quarter and full year 2019 was $29.5 million and

BERWYN, Pa., Feb. 24, 2020 /PRNewswire/ -- Researchers at the University of Texas at Austin and the National Institutes of Health created the first 3D atomic scale map of the 2019 novel coronavirus. This breakthrough will allow for the rapid development of vaccines, therapeutic antibodies, and other medical countermeasures. The researchers use

LONDON, Feb. 24, 2020 /PRNewswire/ -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, is pleased to announce positive long-term data from the ongoing Phase 1/2a clinical trial of its hRPC stem cell therapy candidate in retinitis pigmentosa (RP) and plans to expand the ongoing study.  RP is a group of hereditary dis

CAMBRIDGE, Mass., Feb. 24, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that updated data from the Phase 2 PIONEER trial of avapritinib in patients with indolent systemic mastocytosis will be reported in a late-brea

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ -- Avidity Biosciences (Avidity), a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), announced today that Sarah Boyce, Avidity's President and CEO, will present a company overview at two upcoming investor conferences: